Skip to main content
. 2015 Sep 10;6(33):34245–34257. doi: 10.18632/oncotarget.5196

Figure 2. JAK2 mediates CXCL12-mediated B-lymphocyte underflow adhesion to ICAM-1 and VCAM-1.

Figure 2

Underflow adhesion to ICAM-1 A–B or VCAM-1 C–D. Cells were treated for 1 h with vehicle (Control) or with AG490 100 μM (A–C), or P1 or P1-TKIP 40 μM (B–D). Mean ± SD. *P < 0.001, versus Control (A–C). Mean ± SD. *P < 0.001, versus P1 (B–D). Data are average of n = 10 independent experiments using B-cells isolated from 10 different healthy donors.